Endurant Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-423
| Closed | -$504K | – | 52 |
|
|
2019
Q2 | $504K | Buy |
+423
| New | +$504K | 0.2% | 48 |
|
|
2017
Q4 | – | Sell |
-176
| Closed | -$246K | – | 81 |
|
|
2017
Q3 | $246K | Sell |
176
-143
| -45% | -$200K | 0.07% | 84 |
|
|
2017
Q2 | $356K | Buy |
+319
| New | +$356K | 0.1% | 88 |
|
|
2017
Q1 | – | Sell |
-145
| Closed | -$88K | – | 92 |
|
|
2016
Q4 | $88K | Buy |
+145
| New | +$88K | 0.04% | 73 |
|